In this study, we developed a novel weight loss strategy through yeast microcapsule mediated oral delivery of IL-1β shRNA to regulate the expression of obesity-related gene and inflammatory response. The gene discussed is IL1B; the disease is obesity due to melanocortin 4 receptor deficiency.